- Report
- February 2022
- 87 Pages
Global
From €4322EUR$4,500USD£3,721GBP
- Report
- August 2020
- 142 Pages
Global
From €4322EUR$4,500USD£3,721GBP
- Report
- July 2022
- 176 Pages
Global
From €3319EUR$3,456USD£2,858GBP
- Book
- February 2024
- 640 Pages
- Book
- October 2020
- 288 Pages
- Book
- October 2019
- 632 Pages
- Book
- April 2018
- 776 Pages
United States
- Book
- January 2017
- 504 Pages
- Book
- January 2010
- 576 Pages
- Book
- May 2009
- 354 Pages
- Book
- February 2020
- 1152 Pages
- Book
- November 2020
- 314 Pages
- Book
- October 2018
- 308 Pages
Liver cancer is a type of cancer that originates in the liver, an organ located in the upper right side of the abdomen. It is the fifth most common cancer worldwide and the third leading cause of cancer-related death. Symptoms of liver cancer can include abdominal pain, jaundice, and weight loss. Treatment options for liver cancer include surgery, chemotherapy, radiation therapy, and targeted therapy.
The oncology market for liver cancer is highly competitive, with a range of treatments available. Pharmaceutical companies are investing in research and development to develop new treatments and improve existing ones. Additionally, the market is seeing an increase in the number of clinical trials for new treatments.
Companies in the liver cancer market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more
